We are live on
!
Find out more
ACA
Avoro Capital Advisors Portfolio holdings
AUM
$10.2B
1-Year Est. Return
149.19%
This Fund
S&P 500
This Quarter
Est. Return
+9.22%
1 Year Est. Return
+149.19%
3 Year Est. Return
+425.03%
5 Year Est. Return
+775.33%
10 Year Est. Return
+45,729.2%
AUM
$10.2B
AUM Growth
-$22.3M
(-0.22%)
Cap. Flow
-$444M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
76.54%
Holding
36
New
3
Increased
9
Reduced
7
Closed
6
Top Buys
| 1 |
Cytokinetics
CYTK
|
+$212M |
| 2 |
DMRA
Damora Therapeutics
DMRA
|
+$97.2M |
| 3 |
TERN
Terns Pharmaceuticals
TERN
|
+$55.2M |
| 4 |
Celcuity
CELC
|
+$28.8M |
| 5 |
Avalo Therapeutics
AVTX
|
+$22M |
Top Sells
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$393M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$256M |
| 3 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$79.9M |
| 4 |
PTC Therapeutics
PTCT
|
+$52M |
| 5 |
ORKA
Oruka Therapeutics
ORKA
|
+$40.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
GH Research
GHRS
$1.74B
| $25.3M | 0.25% |
1,800,000
| – | – |
|
|
27
Avalo Therapeutics
AVTX
$994M
| $21.1M | 0.21% |
+1,410,000
| New | +$22M |
|
28
Lexeo Therapeutics
LXEO
$364M
| $10.8M | 0.11% |
1,875,000
-1,425,000
| -43% | -$10.1M |
|
|
WHWK
29
Whitehawk Therapeutics
WHWK
$190M
| $9.83M | 0.1% |
2,849,402
| – | – |
|
30
MannKind Corp
MNKD
$1.25B
| $5.39M | 0.05% |
2,200,000
-2,244,444
| -50% | -$10M |
|
31
Apogee Therapeutics
APGE
$10.1B
| – | – |
-500,000
| Closed | -$37.7M |
|
32
Incyte
INCY
$22.8B
| – | – |
-135,000
| Closed | -$13.3M |
|
|
33
PTC Therapeutics
PTCT
$6.75B
| – | – |
-685,000
| Closed | -$52M |
|
|
RNAM
34
DELISTED
Avidity Biosciences
RNAM
| – | – |
-5,455,000
| Closed | -$393M |
|
|
35
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| – | – |
-2,100,000
| Closed | -$256M |
|
|
ORKA
36
Oruka Therapeutics
ORKA
$5.1B
| – | – |
-1,333,340
| Closed | -$40.4M |
|
Similar funds
GI
IIM
RA
GT
VPIM
OIA
ECM
BEI